Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
Clinical trial NCT00077298 · COMPLETED
Trial details
- NCT number
- NCT00077298
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2007-07-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.